SCHEMBL7962574

SCHEMBL7962574

COC(c1ccccc1)(c1ccccc1)c1cc2cccc(O)c2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.42
ADORA1 P30542 4/20 0.42
ADORA3 P0DMS8 3/20 0.42
MAOA P21397 4/20 0.40
MAOB P27338 3/20 0.40
AKR1C3 P42330 5/20 0.36
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
LCK P06239 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HTT P42858 1/20 0.34
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25094249 0.74 MAOA (0.47) ADORA2AADORA1ADORA3MAOAMAOB
SCHEMBL13645096 0.69 ESR1 (0.39) CA1CA2SMN1; SMN2KDM4EMAPT
Methoxytriphenylmethane SCHEMBL9103 0.67 MAPK1 (0.48) CA4
Methoxytriphenylmethane SCHEMBL27882817 0.65 MAPK1 (0.46) MEN1KMT2AKDM4ECA4
SCHEMBL5003621 0.64 MAOA (0.59) ADORA2AADORA1ADORA3MAOAMAOB
SCHEMBL30892693 0.64 MAOA (0.66) ADORA2AADORA1ADORA3MAOAMAOB
SCHEMBL4674251 0.63 LMNA (0.53) ADORA2AADORA1ADORA3MAOAMAOB
SCHEMBL18878438 0.62 MAOA (0.49) ADORA2AADORA1ADORA3MAOAMAOB
SCHEMBL28792272 0.61 MAOA (0.49) ADORA2AADORA1ADORA3MAOAMAOB
SCHEMBL10236240 0.61 MAOA (0.48) ADORA2AADORA1ADORA3MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323235-B1 CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS AND ENZYME INHIBITORS OHTAKE ATSUSHI (JP) 2001-11-27 US disclosed
US-6043264-A A THROMBOXANE A2 RECEPTOR ANTAGONIST FOR TREATING HYPERTENSION, THROMBOSIS, ISCHEMIC HEART DISEASES, CIRCULATORY DISEASES, ARTERIOSCLEROSIS, PLATELET FUNCTION DISORDER, HYPERLIPIDEMIA, NEPHRITIS OR ASTHMA TORAY INDUSTRIES, INC. (JP) 2000-03-28 US disclosed
EP-0751126-A1 BENZENE-FUSED HETEROCYCLIC DERIVATIVE AND USE OF THE SAME TORAY INDUSTRIES, INC. (JP) 1997-01-02 EP disclosed